Company

Correvio Pharma Corp. (0001036141)

Standardized SEC financial data for Correvio Pharma Corp. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001036141 · Pharmaceutical Preparations.

Gross margin

69.9%

Operating margin

-84.1%

Net margin

-107.8%

Revenue growth (YoY)

13.8%

Return on equity

1000.0%

ROIC

-44.0%

Free cash flow

-$27.2M

Debt / equity

-78.45×

Ratios for fiscal year 2019, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018	FY2019
Revenue	$25.3M	$24.0M	$28.7M	$32.6M
Cost of revenue	$6.3M	$6.8M	$8.3M	$9.8M
Gross profit	$18.9M	$17.2M	$20.4M	$22.8M
R&D expense	$0	$0	—

Balance sheet

USD	FY2016	FY2017	FY2018	FY2018	FY2019
Cash & equivalents	$29.3M	$24.2M	—	$17.6M	$15.2M
Accounts receivable	$6.2M	$6.4M	—	$7.7M	$12.0M
Inventory	$4.6M	$4.6M	—	$4.2M	$3.6M
Total current assets

Cash flow

USD	FY2016	FY2017	FY2018	FY2019
Operating cash flow	-$15.9M	-$24.8M	-$25.8M	-$27.1M
Capital expenditures	$9K	$5K	$284K	$129K
Free cash flow	-$15.9M	-$24.8M	-$26.1M	-$27.2M
Investing cash flow	-$13.6M	-$5.2M	$14.1M	$215K

Get 0001036141 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001036141/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001036141/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001036141 filings on SEC EDGAR →